Direkt zum Inhalt
Merck

p50 (NF-κB1) is an effector protein in the cytotoxic response to DNA methylation damage.

Molecular cell (2011-12-14)
Adam M Schmitt, Clayton D Crawley, Shijune Kang, David R Raleigh, Xiaohong Yu, Joshua S Wahlstrom, David J Voce, Thomas E Darga, Ralph R Weichselbaum, Bakhtiar Yamini
ZUSAMMENFASSUNG

The functional significance of the signaling pathway induced by O(6)-methylguanine (O(6)-MeG) lesions is poorly understood. Here, we identify the p50 subunit of NF-κB as a central target in the response to O(6)-MeG and demonstrate that p50 is required for S(N)1-methylator-induced cytotoxicity. In response to S(N)1-methylation, p50 facilitates the inhibition of NF-κB-regulated antiapoptotic gene expression. Inhibition of NF-κB activity is noted to be an S phase-specific phenomenon that requires the formation of O(6)-MeG:T mismatches. Chk1 associates with p50 following S(N)1-methylation, and phosphorylation of p50 by Chk1 results in the inhibition of NF-κB DNA binding. Expression of an unphosphorylatable p50 mutant blocks inhibition of NF-κB-regulated antiapoptotic gene expression and attenuates S(N)1-methylator-induced cytotoxicity. While O(6)-MeG:T-induced, p50-dependent signaling is not sufficient to induce cell death, this pathway sensitizes cells to the cytotoxic effects of DNA breaks.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Anti-NFκB p65 Antibody, CT, Upstate®, from rabbit